It is well-documented that the protective effect of exogenous FGF21 on obesity and T2DM is closely depends on the activation of SIRT1 and subsequently leads to the deacetylation of its downstream targets, PGC-1α and H3 in human adipocytes (81). Here, FGF21 is linked to obesity disorder.